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Abstract
Occupational exposures play a role in the onset of several chronic airway diseases. We
investigated, in a cross-sectional study, lung function parameters and bronchial hyper-
responsiveness to histamine in workers exposed to different airborne compounds.
The study group totalled 546 male subjects of whom 114 were exposed to welding fumes, 106 to
solvents, 107 to mineral dust, 97 to organic dust and 123 without known exposure to airway
irritants. A questionnaire was administered and spirometry and bronchial responsiveness to
histamine were assessed by one observer, in the morning before work to prevent effects of acute
exposure.
The mean (SD) age of the participants was 39.3 (7.8) years, with a mean duration of employment
of 13.8 (6.6) years. Both before and after adjustment for smoking status, forced expiratory volume
in 1 second (FEV1, expressed as % predicted) was lower in welders -4.0% (95% confidence interval
[CI], -6.3 to -1.8; p = 0.01) and workers exposed to solvents -5.6% (CI: -7.9 to -3.3; p = 0.0009)
than in control subjects. Furthermore, solvent workers had an odds ratio of 3.43 (95% CI: 1.09–
11.6; p = 0.037) for bronchial hyperresponsiveness compared with the reference group.
The higher prevalence of bronchial hyperresponsiveness in solvent workers adds to the growing
body of evidence of adverse respiratory effects of occupational solvent exposure. These results
point to the necessity of preventive measures in solvent workers to avoid these adverse
respiratory effects.
Background
Although the dominant cause of chronic obstructive pul-
monary disease (COPD) is cigarette smoking, there is lit-
tle doubt that chronic occupational exposures to various
agents contribute to the incidence and the severity of
chronic airways disease, including COPD [1-4]. The quan-
titative contribution of occupational factors to the burden
of COPD morbidity or mortality has been recently esti-
mated at about 15% [5]. This value corresponds to the
median of the attributable fractions of occupation to the
occurrence of COPD, as derived from published popula-
tion studies or occupational cohort studies.
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These studies have been mainly concerned with occupa-
tional exposures to mineral dusts (in mines, metal indus-
tries or construction) or to organic dusts (in agriculture or
agro-industry). The effects of exposure to irritant gases
and vapors have not been investigated as much, and in
particular the long-term respiratory effects of chronic
occupational exposure to organic solvents are not well
known [6].
Most epidemiological studies of the impact of occupation
on the respiratory tract have used questionnaires and
spirometry. Forced vital capacity (FVC) and Forced expir-
atory volume in one second (FEV1) are currently the best
available functional measures and predictors of respira-
tory (and even general) health [7]. However, the individ-
ual risk factors that determine the susceptibility to an
accelerated decrease in pulmonary function in smokers
and/or occupationally exposed subjects are still largely
unknown. One possibility is that nonspecific bronchial
hyperresponsiveness is such a risk factor [8]. Although
bronchial hyperresponsiveness has been assessed in many
epidemiological studies, including in children (mainly in
relation to asthma) [9], its prevalence and possible deter-
minants have been studied in only few studies related to
occupation [10-13].
In the present cross-sectional study, conducted in Algeria,
pulmonary function and bronchial responsiveness to his-
tamine were assessed in workers exposed to various com-
mon classes of agents, including mineral dusts, organic
dusts, welding fumes and solvents. The main research
question was whether the prevalence of bronchial hyper-
responsiveness in these occupational groups differs from
that in a control population of unexposed workers.
Methods
Study design
The survey took place between January and October 1996.
Factories situated within a radius of 40 km of Oran, Alge-
ria, and with presumed substantial exposure to one of the
substances of interest (welding fumes, solvents, organic
dust and mineral dust) and more than 20 workers
employed, were selected. Eligible participants were men
who had worked in the selected factories for at least two
years. The control group included workers with life-long
employment at the National Company for Gas and Elec-
tricity of Algeria (Sonelgaz) located in the same geograph-
ical area as the exposed workers. In total 620 workers
fulfilling the selection criteria were selected, of whom 576
(93%) agreed to participate.
The group exposed to mineral dust comprised grinders
from a metallurgical plant, quarry workers, underground
mineworkers from a Kieselguhr (diatomite) mine, work-
ers processing Kieselguhr, workers from a cement factory,
and oven bricklayers from a steel factory. The group
exposed to organic dust was composed of employees from
five different cereal grain silos, working as loaders/
unloaders or in cleaning/repairing jute bags to transport
grain.
The group of welders came from a shipbuilding company
and a metallurgic plant making water tanks; the metals
welded (mainly steel) and the welding processes (mainly
manual welding) were comparable in both plants. The
group of solvent-exposed workers was composed mainly
of workers from a paint manufacturing plant, and also
spray-painters from the shipbuilding company. These
subjects were exposed to xylene, toluene, white-spirit, eth-
yleneglycolacetate, methyl isobutyl ketone and butanol.
The study was performed in accordance with the Helsinki
Declaration and was approved by the ethical board of the
University of Oran. We obtained informed written con-
sent from the workers.
Questionnaire
Data on smoking, respiratory symptoms, and diseases
were collected by a face-to-face interview with questions
based on the 1987 version of the European Coal and Steel
Community respiratory questionnaire [14]. Non-smokers
were defined as those who had never smoked regularly.
Smokers were those who reported currently smoking at
least one cigarette daily. Ex-smokers included those who
had formerly smoked regularly. The questionnaire further
gathered information on the following symptoms:
chronic cough, chronic phlegm for as much as 3 months
of the year; dyspnoea, defined as shortness of breath dur-
ing low to moderate physical activity; symptoms suggest-
ing asthma or allergy, the use of medication for asthma or
allergy, and the presence of hay-fever and nasal allergies.
Asthma was defined as answering "yes" to the question
"Have you ever had asthma?". Allergic rhinitis was
defined as answering "yes" to the question "Do you have
hay-fever or any other kind of allergic rhinitis?"
Clinical and functional measurements
The subjects were asked to refrain from smoking at least
for one hour prior to testing. Spirometry and bronchial
responsiveness were measured in the morning before
work to prevent effects of acute exposure, by a single
observer (F. Ould-Kadi). Height and weight were meas-
ured to the nearest cm and nearest 0.1 kg, respectively.
FEV1, FVC and forced expiratory flows were obtained
using an electronic spirometer (HI 298, ESSILOR) accord-
ing to the ATS standards [15]. The ratio of FEV1 to FVC was
calculated. Pulmonary function parameters were
expressed as %-predicted according to Quanjer et
al.[16,17]. After collection of the spirometric data, the
same observer measured bronchial reactivity to histamine
in subjects with a FEV1 of more than 60% predicted,Journal of Occupational Medicine and Toxicology 2007, 2:11 http://www.occup-med.com/content/2/1/11
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according to the abbreviated protocol of Yan et al.[18]
Histamine dichloride (Sigma, Belgium) was diluted in
sterile 0.9% saline to concentrations of 10.2 µmol/ml
(solution 1), 20.4 µmol/ml (solution 2), 81.5 µmol/ml
(solution 3) and 163 µmol/ml (solution 4). Aerosols were
generated using five DeVilbiss n°40 hand-operated glass
nebulisers. In preliminary experiments, the average out-
put of the five nebulisers was determined to be 0.03 g
(range 0.028 to 0.039 g; SD: 0.008) for 10 actuations or 3
µl per actuation. Actuation of the aerosol was done at the
start of an inhalation from functional residualcapacity to
total lung capacity over 5 seconds, followed by a 3-second
breath hold. The protocol involved one inhalation of
saline (start value), then of solution 1 (0.03 µmol), then
one inhalation of solution 1 (+0.03 µmol = 0.06 µmol
cumulative), then three inhalations of solution 2 (+0.18
µmol = 0.24 µmol cumulative), then three inhalations of
solution 3 (+0.73 µmol = 0.98 µmol cumulative), then 4
inhalations of solution 3 (+0.98 µmol = 1.96 µmol cumu-
lative) and finally 4 inhalations of solution 4 (+1.96 µmol
= 3.91 µmol cumulative). Sixty seconds after inhaling the
aerosol, subjects performed three to five spirometry
maneuvers (best quality effort selected) followed by inha-
lation of the next higher dose. Administration of increas-
ing histamine concentrations was continued until FEV1
declined by 20% of baseline or the maximum cumulative
dose was achieved (3.9 µmol). Subjects who had taken a
beta-agonist within six hours of the examination were
asked to withhold medication before returning for a later
visit.
The histamine challenge test results can be expressed in a
dichotomous way as the provocative dose of histamine
causing a 20% fall in FEV1 (PD20) or in various other ways
that take into account the entire dataset, even in those
who do not reach a PD20. We calculated the area under the
curve relating percent change in FEV1 against cumulative
histamine dose, from control (0 µmol; starting FEV1 set at
100%) up to the highest dose tested (max 3.9 µmol).
Statistical analysis
We used SAS software version 8.1 (SAS Institute Inc, Cary,
NC) for statistical analysis. For comparison of means and
proportions, we applied Student's t-test and the χ2-statis-
tic, respectively. We used a general linear model and a
logistic regression model to study group differences for
continuous and dichotomous variables, respectively. Mul-
tiple regression models (lung function) and logistic
regression models were adjusted for smoking, duration of
employment, salary and reporting symptoms of allergy.
Results
Population characteristics
Of the 620 men, 576 (93%) agreed to participate, but 10
subjects were absent and 20 subjects with multiple expo-
sures were excluded. Thus, the final study group totalled
546 subjects of whom 114 were exposed to welding
fumes, 106 to solvents, 107 to mineral dust, and 97 to
organic dust. The control group consisted of 123 workers
without known significant exposures.
The characteristics of the 546 study participants are listed
in Table 1. The mean (SD) age of the participants was 39.3
(7.8) years and was slightly but significantly higher in
workers exposed to mineral and organic dust (Table 1).
The mean duration of employment was 13.8 (6.6) years.
Half the subjects (49%; n = 266) were current smokers,
and 28% (n = 155) had never smoked. The mean cumula-
Table 1: Characteristics of the study population stratified by exposure group
Reference 
(n = 123)
Welders 
(n = 114)
Solvents 
(n = 106)
Mineral dust 
(n = 107)
Organic dust 
(n = 97)
Total 
(n = 546)
overall p
Age (years) Mean (SD) 38.3 1,2 (8.3) 37.6 1 (7.6) 39.3 1,2 (6.4) 40.1 2,3 (7.8) 41.8 3 (8.3) 39.3 (7.8) 0.0001
Height (cm) Mean (SD) 173 (6.7) 172.3 (5.9) 171.4 (6.7) 171.8 (6.8) 172.3 (5.8) 172.2 (6.4) NS
Weight (kg) Mean (SD) 69.3 2,3 (10.9) 65.6 1 (10.5) 66.2 1,2 (11.5) 67.3 1,2 (11.6) 713 (12.4) 65.8 (11.5) 0.003
Duration exposure Mean (years) 
(SD)
18 4 (8.5) 13.9 2,3 (5.7) 11.9 1 (4.9) 12.8 1 (6.6) 14.6 3,4 (5.9) 13.8 (6.6) <0.0001
Monthly salary (DA) Mean (SD) 11022 4 (1929) 8383 1 (1692) 9972 3 (1842) 9262 2 (2053) 9989 3 (1622) 9739 (2049) <0.0001
Smoking Habit
Non-smokers n (%) 43 (35) 27 (24) 26 (25) 29 (27) 30 (31) 155 (28.4) NS
Ex-smokers n (%) 26 (25) 25 (22) 17 (13) 30 (28) 27 (28) 125 (22.8) NS
Smokers n (%) 54 1 (44) 62 1,2 (54) 62 2 (59) 48 1 (45) 40 1 (41) 256 (48.8) 0.04
Cigarettes/day* Mean (SD) 15.2 1 (8.1) 17 1 (11) 18.9 2 (9.1) 16.4 1,2 (8.1) 17.3 1,2 (10.5) 16.9 (9.4) NS
Pack years* Mean (SD) 12.9 1 (6.7) 12 1 (5.9) 16.5 2 (6.7) 11.9 1 (6.8) 13.1 1 (5.8) 13.3 (6.4) 0.04
Allergy n (%) 10 1,2 (8.1) 3 1 (2.6) 13 2 (12.4) 4 1 (3.8) 5 1,2 (5.1) 35 (6.4) 0.02
Asthma n (%) 3 (2.4) 3 (2.6) 2 (1.9) 0 (0) 1 (1) 9 (1.6) NS
1,2,3: Groups with the same number in exponent do not differ significantly. *excluding never smokers.
DA: Algerian Dinar
Allergy based on reported symptoms, use of medication for allergy or the presence of hayfever or nasal allergies.Journal of Occupational Medicine and Toxicology 2007, 2:11 http://www.occup-med.com/content/2/1/11
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tive history of smoking, among current smokers and past-
smokers, was 13.3 (10.7) pack-years. The proportion of
smokers was higher in welders (62%) and workers
exposed to solvents (62%) compared with the controls
(54%), while duration of employment and salary were
significantly higher in the control group (Table 1). The
reported symptom prevalences were generally very low,
with only 112 subjects (20.5%) reporting at least one
symptom (13.0% in controls, 18.4% in welders, 32.4% in
solvent group, 21.5% in mineral dust group, 18.6% in
organic dust group). Chronic cough was reported by 22
subjects (4.0%), chronic phlegm by 32 subjects (5.9%),
wheezing by 50 subjects (9.2%), allergy by 35 subjects
(6.4%) and asthma by 9 subjects (1.6%).
When compared to controls, only workers exposed to sol-
vents had a significantly higher prevalence of symptoms,
especially of chronic cough (8.6% vs 0.8%; P = 0.03) and
chronic phlegm (12.4% vs 2.4%; P = 0.01). Smokers had
a higher prevalence of at least one reported symptom
(26.3%) than nonsmokers (14.2%) and exsmokers
(16.0%), this being significant for chronic cough only
(7.5% vs 0.6% and 0.8%, respectively).
Baseline level of pulmonary function
Overall, FEV1 and FVC expressed as percent predicted,[16]
were lower in smokers compared with non-smokers
(97.6% vs 102.1%; P < 0.0001 and 97.9% vs 102.2%; P <
0.0001, respectively), and this was also true for the forced
expiratory flows. The spirometric values of exsmokers did
not differ from those of nonsmokers. Independently of
smoking status, FEV1 tended to increase by 0.15% (SD:
0.08; P = 0.07) per year of employment.
Table 2 shows the pulmonary function variables accord-
ing to the various classes of exposure. In general, the con-
trol group exhibited the highest mean values for all
parameters and the group of solvent-exposed workers had
the lowest values. In comparison with the control group,
FVC and FEV1 were significantly lower in welders and
workers exposed to solvents (Table 2). These differences
remained significant, after adjustment by multiple regres-
sion for smoking status, years of employment and salary,
with FEV1 being 4.0% (95% confidence interval [CI], -6.3
to -1.8; P = 0.01) lower in welders and 5.6% lower (CI: -
7.9 to -3.3; P = 0.0009) in workers exposed to solvents.
The other spirometry findings (FEV1/FVC, MEF50, MEF75)
appeared not to be different across the different exposure
groups (Table 2). The results were not altered when the
adjustment for smoking was made by using number of
pack-years instead of smoking status (not shown).
An obstructive impairment (FEV1/FVC < 0.70) was
present in 24 subjects (4.3%, 13 smokers, 5 exsmokers),
with 3 to 6 subjects only in each group (NS). A possible
restrictive impairment (FVC and FEV1 < 80% predicted
and FEV1/FVC > 0.70) was present in 11 subjects (2.0%,
all smokers), with 1 subject in the control group, 4 sub-
jects in the mineral dust group and 2 in each of the other
three groups (NS).
Bronchial responsiveness
The histamine test was not done in 4 subjects (one subject
in each group, except welders) because of contra-indica-
tions. A decrease in FEV1 by 20% or more, i.e. a PD20
value, was obtained in 31 workers (5.7%) workers (Table
2); decreases in FEV1 by at least 15%, i.e. a PD15 value, or
by at least 10%, i.e. a PD10 value, were obtained in 51 sub-
jects (9.3%) and 95 subjects (17.4%), respectively. These
prevalences were similar for nonsmokers, smokers or
exsmokers.
The analysis of the histamine response using the Area
Under the Curve (AUC) gave a mean value of 371
Table 2: Lung function stratified by exposure group
Reference 
(n = 123)
Welders 
(n = 114)
Solvents 
(n = 106)
Minerals dust 
(n = 107)
Organic dust 
(n = 97)
overall p
FVC (%) Mean (SD) 103.9 3 (12.3) 99.5 1 (12.3) 97.8 1,2 (12.9) 101.5 2,3 (13) 102.5 2,3 (12) 0.03
FEV1 (%) Mean (SD) 102.7 3 (12.4) 98.3 1,2 (12.9) 96.2 1 (13.4) 101.1 2,3 (12) 101.8 2,3 (13.8) 0.01
FEV1/FVC (%) Mean (SD) 82.1 (6.0) 82.2 (6.2) 81.8 (7.3) 82.5 (5.8) 81.7 (6.8) NS
PEF (%) Mean (SD) 92.5 3 (15.6) 87.1 2 (14.8) 81.8 1 (15.5) 88.5 2,3 (15.5) 90.6 2,3 (17) <0.0001
MEF25 (%) Mean (SD) 89.7 2 (19.5) 84.3 1,2 (18) 80.8 1 (19.2) 86.6 2 (18.4) 88.4 2 (21.9) <0.0001
MEF50 (%) Mean (SD) 85.9 (22.2) 81.5 (23.4) 79.3 (23.9) 82.9 (22.2) 85.1 (24.6) NS
MEF75 (%) Mean (SD) 74.2 (21.6) 72.2 (20.8) 70.3 (24.6) 74.5 (20.1) 74.2 (23.1) NS
MMEF (%) Mean (SD) 79 2 (21.2) 74.9 1,2 (22.8) 72 1 (22.7) 76.4 1,2 (19.5) 77.8 1,2 (23) 0.16
PD20 Number (%) 4 (3)1 6 (5)1,2 11 (11)2 6 (6)1,2 4 (4)1,2 NS
FVC (Forced Vital Capacity), FEV1 (Forced Expiratory Volume in 1 Second), PEF (Peak Expiratory Flow), MEF (Maximal Expiratory Flow at given 
percentage of FVC), MMEF (Maximal Mid-Expiratory Flow), all expressed as percent predicted (according to Quanjer et al. [15]), except for FEV1/
FVC where real percentage is given (ratio × 100). PD20: number of subjects with a measurable PD20 (provocative dose of histamine leading to a 20% 
decrease in FEV1 with respect to the starting value) in the histamine test (n values of group lower by one in each group except in welders).
1,2,3: groups with the same number in exponent do not differ significantlyJournal of Occupational Medicine and Toxicology 2007, 2:11 http://www.occup-med.com/content/2/1/11
Page 5 of 8
(page number not for citation purposes)
µmol.%FEV1 (range 312–412). Values higher than 390
were obtained in those whose FEV1 increased above the
starting value. Among subjects without a detectable PD20
the mean value was 379 µmol.%FEV1 (range 320–412),
and among subjects with a detectable PD20 the mean
value was 251 µmol.%FEV1 (range 312–346). Neither for
the dichotomous (PD20) nor the continuous (AUC) vari-
ables of bronchial hyperresponsiveness, was there a rela-
tion with age, smoking, the duration of employment, or
symptoms of allergy. There was also no interaction
between age and smoking for these parameters. However,
the odds of having a detectable PD20 was 18.8 (95% C.I.
4.5–79.1, P < 0.001) in those reporting asthma symptoms
(9 subjects).
The presence of bronchial hyperresponsiveness, defined
as a measurable PD20, was more frequent in solvent work-
ers compared with controls (11% vs 3%; P = 0.028), yield-
ing an odds ratio for bronchial responsiveness of 3.43
(95% CI: 1.05–11.1; P = 0.04) in solvent workers com-
pared with controls, independently of the aforemen-
tioned covariates. Using the area under the curve as a
continuous measure of bronchial responsiveness, con-
firmed the dichotomous analysis, before (figure 1) and
after adjustment for the same covariates: the AUC was
2.9% (CI: -0.9% to -4.7%; P = 0.04) lower in workers
exposed to solvents compared with the controls. How-
ever, no significant differences were obtained for the other
groups.
Discussion
Key findings in our study are that workers exposed to
metal fumes and solvents had a lower baseline lung func-
tion and that solvent-exposed workers had a 3.4 times
higher risk of having nonspecific bronchial hyperrespon-
siveness than the reference group.
Respiratory symptoms
In this population the prevalence of respiratory symptoms
was low. Apart from the fact that this was a relatively
young working population, it is possible that the respond-
ents were fearful of admitting symptoms and/or that the
questionnaire utilized [14] did not capture respiratory
symptoms as well as in the European populations where
it was developed. Nevertheless, as expected, smokers
reported more symptoms than nonsmokers and exsmok-
ers.
The prevalence of asthma (1.6%) and allergy (6.4%) also
appeared to be very low. Again, this may reflect a healthy
worker effect or be due to a validity issue of the question-
naire utilized, but it is also compatible with the low prev-
alence of atopy and asthma in North Africa, at least in
children [17].
Pulmonary function
The spirometric data were generally well within the range
of normality as defined by the prediction equations of
Quanjer et al.[16]. Smokers had slightly but significantly
poorer values than nonsmokers and exsmokers, which
indicates that the quality of the measurements was ade-
quate. The trend (P = 0.07) for an improvement in FEV1
with duration of employment may be due to a healthy
worker effect.
Only few data on pulmonary function have been pub-
lished from populations with occupational exposure to
solvents. A cross-sectional study on the association
between pulmonary function and solvent exposure in
workers of an automobile paint and coating plant showed
a negative correlation between FEV1 and years of solvent
exposure [19]. Data on 15,637 people aged 20–44, ran-
domly selected from the general population of 26 areas in
12 industrialised countries showed that the highest risk of
asthma, defined as bronchial hyperresponsiveness and
reported asthma symptoms or medication, was observed
for farmers (odds ratio 2.62 [95% CI 1.29–5.35]), paint-
ers (2.34 [1.04–5.28]), plastic workers (2.20 [0.59–
8.29]), cleaners (1.97 [1.33–2.92]), and spray painters
(1.96 [0.72–5.34])[20]. In a cross-sectional study in a
sample of furniture workers exposed to isocyanate paints,
the risk of asthma in the exposed group was 2.1% versus
0.8% in controls (P = 0.07)[21]. There was no recorded
evidence for the use of polyurethane paints in the present
group.
Histamine responsiveness Figure 1
Histamine responsiveness. Mean FEV1 as the percentage 
of the initial value (0) after increasing doses of inhaled hista-
mine, administered by aerosol by a hand held nebuliser, 
according to exposure group. Error bars have been deleted 
for clarity. * denotes significant difference (p < 0.05) com-
pared with controls. At the higher doses the numbers of sub-
jects are slightly lower than indicated in the legend because 
the test was interrupted when FEV1 decreased by 20% or 
more (i.e. detectable PD20, see table 2 for the number of 
subjects with a detectable PD20 in each group).Journal of Occupational Medicine and Toxicology 2007, 2:11 http://www.occup-med.com/content/2/1/11
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The group of welders also had a slightly poorer pulmo-
nary function. Our findings are consistent with those from
Akbar-Khanzadeh [22] who reported a greater deteriora-
tion of lung function with advancing age in welders com-
pared with controls. In a longitudinal study of welders
and caulker-burners with follow-up of retired workers,
Chinn and colleagues [23] demonstrated that FVC, FEV1,
PEF, and FEF50% declined over time; the decrease was
caused equally by welding and smoking. In 286 students
entering an apprenticeship programme in the welding
profession FEV1 dropped on average by 8.4% (P = 0.01)
during the follow-up of 15 months [23]. However, in con-
trast to the above results, several investigators have found
no overall effect of welding on lung function. Our study
included welders in confined and poorly ventilated
spaces, like shipbuilding. The contradictory results regard-
ing lung function in welders could be caused by differ-
ences with regard to healthy worker selection, smoking
habits, co-exposure to asbestos, workplace variability, the
welding materials used, the amount of ventilation, and
the kinds of protective measures taken.
The functional impairment observed in solvent-exposed
workers and welders was not entirely typical for bronchial
obstruction since FEV1 and FVC were decreased to a simi-
lar extent. In the absence of measurements of total lung
capacity, it is not possible to attribute the observed
changes to lung restriction. The number of subjects with
FEV1 and FVC values below 80% pred. with FEV1/FVC >
0.70 (2 in each category) was low and it did not differ sig-
nificantly from the numbers observed in the controls. It is
possible that exposure to some occupational agents, and
solvents in particular, reduces both FEV1 and FVC, as
shown, for instance, in recent studies of workers exposed
to coke oven emissions [24], cement dust [25] or dust
from the collapsed World Trade Center [26].
In contrast to some other reports [24,27,28], we did not
observe adverse respiratory effects of exposures to organic
dust and mineral dust. Individuals susceptible to adverse
respiratory effects from organic or mineral dust may have
quit work and therefore dropped out of the exposed
group. This may explain the higher mean FVC among
workers exposed to mineral dust. In the current study,
FVC and FEV1 increased marginally with years of employ-
ment suggesting that a healthy worker effect might have
occurred and weakened the observed associations.
Because of the cross-sectional nature of this study, it is not
possible to differentiate the effects of current exposure
from those of cumulative exposure. Another limitation is
that we had no exposure measurement data, neither at the
individual nor at the group level.
Nonspecific bronchial hyperresponsiveness
In the present study, bronchial responsiveness to hista-
mine was not influenced by smoking status. Smoking per
se does not appear to affect airway responsiveness.
Although as a group smokers have somewhat higher bron-
chial responsiveness than nonsmokers, this difference dis-
appears when baseline airway calibre (FEV1) is taken into
account [29]. Also, smoking and atopy act synergistically
to increase airway reactivity [30], but this was not appar-
ent in the present population, probably because there
were only few atopic subjects.
We studied bronchial hyperresponsiveness using hista-
mine as the bronchoconstrictor, as in the abbreviated pro-
tocol of Yan et al. [18]. Even though histamine and
methacholine are not fully interchangeable, both agents
provide concordant results [31]. We studied bronchial
responsiveness both as a dichotomous variable (PD20)
and as a continuous variable. A detectable PD20 is used
clinically, because it is simple to understand and it is clin-
ically relevant. However, such dichotomous response
only gives useful information for those subjects having a
measurable PD20. Replacing a parameter that is continu-
ous with one that is dichotomous is not only arbitrary but
results also in less phenotypic precision, especially for epi-
demiological studies. Therefore, continuous measures of
bronchial hyper-responsiveness have been proposed,
such as that of O'Connor et al. [30] or the BRindex [32]. A
disadvantage of the latter two methods is that they discard
information as well, since they assess the percentage fall in
FEV1 at the highest dose relative to baseline. Hence, these
two measures need to be used with caution because they
are largely influenced by "error" in the fall of FEV1 at the
final dose. This is why we chose to calculate the area under
the curve relating the % change in FEV1against cumulative
histamine dose from 0 to 3.9 µmol. To our knowledge,
this has not been done by others.
As indicated in the introduction, only few data are availa-
ble concerning bronchial responsiveness in adult working
populations. In a cross-sectional study of 688 male work-
ers, Kremer et al. [13] found no association between low
grade exposure to various airway irritants and airway
hyperresponsiveness, which was determined both as PC20
and as a slope according to O'Connor [30]. That study did
not contain solvent-exposed painters or welders. Beckett
et al. [10] measured spirometry and methacholine reactiv-
ity annually for three years in 51 welders and 54 non-
welder control subjects: no effect of welding was found on
methacholine reactivity, neither at baseline, nor during
follow-up. This confirmed negative findings from a
smaller study of welders [33]. In the European Commu-
nity Respiratory Health Survey (ECRHS) associations were
studied, in 13,253 men and women of 20 to 44 y, between
occupational exposures and various indices, includingJournal of Occupational Medicine and Toxicology 2007, 2:11 http://www.occup-med.com/content/2/1/11
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spirometry and methacholine responsiveness [11].
Although some occupational exposures (especially agri-
culture) were found to contribute to bronchitis symp-
toms, neither lung function, nor bronchial responsiveness
were related to any of the occupational exposures indices,
none of which, however, included solvents as a specific
category [11].
On the basis of both PD20 and the AUC method for
expressing bronchial responsiveness, we found that sol-
vent exposed workers had a higher bronchial response to
histamine. However, with the present data it cannot be
determined whether the higher bronchial responsiveness
reflects the somewhat lower FEV1 in this group or whether
they had a lower FEV1 because they had bronchial hyper-
responsiveness. In the latter case, this would strengthen
the hypothesis that bronchial responsiveness is a risk fac-
tor for an accelerated decline in ventilatory function [8].
Research on occupational safety and health is occasionally
carried out jointly between the industrialized and devel-
oping countries. The present study must be interpreted
within the context of its limitations. Observational studies
cannot prove causation. Occupational health remains
limited in Northern Africa because of competing social,
economic, and political challenges. Although no quanti-
fied exposure data were available, it might be assumed
that compared with North-American and West-European
standards, high exposure to the studied agents occurred
since no or very little preventive measures were adopted in
these Algerian work places at the time of the study. Besides
limited or no quantified exposure and the rather low
duration of employment, other factors might have biased
our estimates. Thus, although the control group also con-
sisted of blue-collar workers, these proved to have a
higher income and to smoke less. This difference in soci-
oeconomic status may be unfortunate for the purposes of
the study, but such confounding should not be too sur-
prising: healthier jobs are often paid better and this can be
expected to lead to better nutrition and lifestyle [34].
In conclusion, baseline FEV1 was lower in smokers and,
independently of smoking status, lower in workers
exposed to solvents and metal fumes. Further, our results
showed an increased prevalence and degree of bronchial
hyperresponsiveness in solvent workers compared with
controls.
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